Syncom Formulations (India) Ltd Shows Strong Performance in Pharmaceutical Industry, Outperforms Sector and Sensex
On July 8th, 2024, Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, saw a 7.24% increase in its stock, outperforming the sector by 7.59%. With a 'Hold' recommendation from MarketsMojo, the company's stock is trading higher than its moving averages and has also outperformed India's benchmark stock index, Sensex.
Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has seen a positive trend in its stock performance on July 8th, 2024. The stock gained 7.24% on this day, outperforming the sector by 7.59%. This marks the second consecutive day of gains for the company, with a total increase of 8.85% in the past two days.
According to MarketsMOJO, a leading stock analysis platform, the current recommendation for Syncom Formulations (India) Ltd is 'Hold'. This is based on the company's recent performance and market trends.
In terms of moving averages, Syncom Formulations (India) Ltd is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend in the stock's performance.
On a broader scale, Syncom Formulations (India) Ltd has also outperformed the Sensex, India's benchmark stock index, in both short-term and long-term performance. The stock's 1-day performance was 7.55% compared to Sensex's -0.17%, while its 1-month performance was 14.80% compared to Sensex's 4.13%.
Overall, Syncom Formulations (India) Ltd has shown a strong performance in the pharmaceutical industry, with a positive trend in its stock performance. Investors may want to keep an eye on this smallcap company as it continues to make strides in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
